Roche has inked a new deal with Dyno Ther­a­peu­tics to de­vel­op next-gen­er­a­tion AAV cap­sids for gene ther­a­pies tar­get­ing neu­ro­log­i­cal dis­eases, ex­pand­ing the ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

New strategic partnership leverages the power of the Dyno platform, enabling Roche to advance next-generation AAV gene therapies across multiple targets Dyno to receive US$50 million upfront cash ...

Roche will apply Dyno Therapeutics’ engineered adeno-associated virus (AAV) capsid platform to develop next-generation AAV vectors for gene therapies targeting unspecified neurological diseases ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...

Explosives and blasting company Dyno Nobel has been going for 180 years, but it now has its sights set on the future of the sector. Braden Lusk, chief technology and marketing officer at the company, ...

Inertial Labs has unveiled the KERNEL-201, the latest addition to its line of miniature MEMS sensor-based inertial measurement units (IMUs). The KERNEL-201 features three-axis MEMS accelerometers and ...

its advanced miniature MEMS sensor-based Inertial Measurement Unit (IMU) family. The KERNEL-201 sets a new standard in compact, high-performance IMUs, offering exceptional accuracy and reliability in ...